Ali Khademhosseini | |
|---|---|
 Khademhosseini in 2022 | |
| Born | October 30, 1975 |
| Education | University of Toronto (BSc, MASc) Massachusetts Institute of Technology (PhD) |
| Awards | Mustafa Prize, PECASE |
| Scientific career | |
| Fields | |
| Institutions | |
| Theses | |
| Doctoral advisor | Robert S. Langer |
| Other academic advisors | Peter Zandstra |
Ali Khademhosseini (Persian: علی خادمحسینی, born October 30, 1975) is an Iranian-born Canadian-American engineer. He is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc.[1] Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT).[2] From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
- ^ "Terasaki Institute Welcomes New Director". Retrieved 28 August 2023.
- ^ "Advanced Science Hall of Fame". 29 July 2019. Retrieved 28 August 2023.